Home > News > A Rexahn, UMD Partnership
February 9th, 2006
A Rexahn, UMD Partnership
Abstract:
Rexahn Pharmaceuticals Inc., a Rockville biotech company, is partnering with University of Maryland School of Pharmacy's Center for Nanomedicine and Cellular Delivery to develop drugs targeting cancer and central nervous system disorders. (last article on the page)
Source:
washingtonpost.com
Bookmark:
| Related Links |
Center for Nanomedicine and Cellular Delivery
| Related News Press |
Nanomedicine
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Announcements
Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Ultrafast plasmon-enhanced magnetic bit switching at the nanoscale April 25th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||